scPharmaceuticals
SCPH
SCPH
95 hedge funds and large institutions have $146M invested in scPharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 32 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
+7
Holders Change %
+7.95%
% of All Funds
1.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
20
Increased
29
Reduced
32
Closed
13
Calls
$4.21M
Puts
–
Net Calls
+$4.21M
Net Calls Change
+$3.83M
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$3.26M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$1.92M |
| 3 |
Millennium Management
New York
|
$2.05M |
| 4 |
Luther King Capital Management (LKCM)
Fort Worth,
Texas
|
$13.5M |
| 5 |
Morgan Stanley
New York
|
$8.18M |
